Comparative cultural study using the Public Attitudes Toward Epilepsy Scale (PATE scale) in Japan and Malaysia
Psychiatry and Clinical Neurosciences Reports · 2025-03 · 4 (1)
DOI: 10.1002/pcn5.70063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychiatry and Clinical Neurosciences Reports, online erschienen am 23.03.2025. Verfasst von Hiroumi Shimazaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Public Interest Foundation of Nishi Kumagaya Hospital Saitama Japan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Epilepsy Research Foundation.
Abstract (Originalsprache)
Aim
Epilepsy‐related stigma significantly impacts quality of life, with severity noted in Asian countries. This study compared public attitudes towards epilepsy in Japan and Malaysia, two Asian nations with distinct religious and healthcare backgrounds.
Methods
We used the Public Attitudes Toward Epilepsy (PATE) scale, including its Japanese version (PATE‐J), to survey 113 Japanese and 130 Malaysian participants. Demographic data and PATE scores were compared using t ‐tests and χ ² tests. Covariance analysis (ANCOVA) was conducted to adjust for potential confounding factors such as age and education level.
Results
No significant differences were found in PATE total scores ( P = 0.484), general domain ( P = 0.101), or personal domain ( P = 0.217) between Japan and Malaysia. However, after adjusting for age and education using ANCOVA, education significantly influenced the general domain ( F = 4.512, P = 0.012) and total scores ( F = 3.302, P = 0.038), while country ( F = 7.191, P = 0.008) and age ( F = 6.633, P = 0.011) were significant for the personal domain. Malaysian participants were significantly younger ( P < 0.001) and had higher education levels ( P < 0.001) compared to Japanese participants.
Conclusion
While no significant differences in epilepsy‐related stigma were observed between Japan and Malaysia, demographic variations in age, education, and regional characteristics may have masked potential cultural differences. The adjusted analysis underscores the importance of controlling for these factors to better elucidate cultural influences on epilepsy stigma formation in Asia.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Public Interest Foundation of Nishi Kumagaya Hospital Saitama Japan.
- Department of Psychiatry Saitama Medical Center, Saitama Medical University Saitama Japan.
- Department of Psychology Showa Women's University Tokyo Japan.
- Higashi Matsuyama Hospital, Medical Corporation Ryokukokai Saitama Japan.
- Division of Neurology, Department of Medicine Faculty of Medicine, University of Malaya Kuala Lumpur Malaysia.
ORCID-Profile: Takayuki Iwayama, Sayaka Kobayashi, Haruo Yoshimasu, Kheng Seang Lim, Izumi Kuramochi
Förderung
- Japan Society for the Promotion of Science
- Japan Epilepsy Research Foundation
Zitieren
APA
Shimazaki, H., Iwayama, T., Kobayashi, S., Hatakeda, J., Chia, Z. J., Yoshimasu, H., Lim, K. S., & Kuramochi, I. (2025). Comparative cultural study using the Public Attitudes Toward Epilepsy Scale (PATE scale) in Japan and Malaysia. Psychiatry and Clinical Neurosciences Reports, 4(1). https://doi.org/10.1002/pcn5.70063
Vancouver
Shimazaki H, Iwayama T, Kobayashi S, Hatakeda J, Chia ZJ, Yoshimasu H, et al. Comparative cultural study using the Public Attitudes Toward Epilepsy Scale (PATE scale) in Japan and Malaysia. Psychiatry and Clinical Neurosciences Reports. 2025;4(1). doi:10.1002/pcn5.70063
BibTeX
@article{Shimazaki2025,
author = {Shimazaki, Hiroumi and Iwayama, Takayuki and Kobayashi, Sayaka and Hatakeda, Junichi and Chia, Zhi Jien and Yoshimasu, Haruo and Lim, Kheng Seang and Kuramochi, Izumi},
title = {Comparative cultural study using the Public Attitudes Toward Epilepsy Scale (PATE scale) in Japan and Malaysia},
journal = {Psychiatry and Clinical Neurosciences Reports},
year = {2025},
volume = {4},
number = {1},
doi = {10.1002/pcn5.70063}
}
EUVIMED